Zhao Jing Selected Research

Zhao Jing Research Topics

Disease

20	Neoplasms (Cancer) 12/2021 - 01/2005
7	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 05/2004
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2016
5	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 09/2015
5	Carcinoma (Carcinomatosis) 10/2017 - 12/2009
4	Esophageal Squamous Cell Carcinoma 11/2020 - 01/2018
4	Lung Neoplasms (Lung Cancer) 10/2017 - 01/2009
3	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 09/2017
3	Carcinogenesis 12/2018 - 02/2005
2	Primary Ovarian Insufficiency 02/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 12/2021 - 02/2005
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 11/2020 - 01/2018
1	Postoperative Pain 04/2022
1	Pain (Aches) 04/2022
1	Osteolysis 12/2021
1	Neuroinflammatory Diseases 01/2021
1	Cerebral Hemorrhage 01/2021
1	Brain Edema (Cerebral Edema) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Osteoporosis 12/2020
1	Rheumatoid Arthritis 12/2020
1	Pancreatitis 10/2020
1	Tonsillitis 09/2020
1	Parotitis (Parotiditis) 09/2020
1	Pharyngitis (Sore Throat) 09/2020
1	Ischemic Stroke 01/2019
1	Stroke (Strokes) 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Bacterial Infections (Bacterial Infection) 06/2017
1	Congenital Heart Defects (Congenital Heart Defect) 06/2016
1	Adenocarcinoma 09/2015
1	Leukemia 02/2014
1	Melanoma (Melanoma, Malignant) 08/2013
1	Lymphatic Metastasis 08/2013
1	Cutaneous Malignant Melanoma 08/2013

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2005
4	ErbB Receptors (EGF Receptor)IBA 07/2019 - 12/2009
3	Tyrosine Kinase InhibitorsIBA 07/2019 - 01/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2018
2	Small Interfering RNA (siRNA)IBA 01/2021 - 09/2016
2	Gefitinib (Iressa)FDA Link 11/2020 - 01/2016
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2020 - 01/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2020 - 01/2018
2	chemotactic factor inactivatorIBA 11/2020 - 09/2017
2	linifanibIBA 10/2020 - 10/2014
2	icotinibIBA 10/2020 - 05/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 05/2005
2	Pharmaceutical PreparationsIBA 12/2018 - 03/2016
2	VimentinIBA 03/2015 - 02/2014
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2005 - 02/2005
1	ravoxertinibIBA 12/2021
1	Conditioned Culture MediaIBA 12/2021
1	Interleukin-4 (Interleukin 4)IBA 12/2021
1	Proto-Oncogene Proteins c-fynIBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Caspase 1 (ICE Protease)IBA 01/2021
1	src-Family KinasesIBA 01/2021
1	hydroxide ionIBA 12/2020
1	Vitamin D FDA LinkGeneric 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Interleukin-10 (Interleukin 10)IBA 12/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2020
1	Pudilan xiaoyanIBA 09/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Beclin-1IBA 01/2019
1	AdipokinesIBA 01/2019
1	LeptinIBA 01/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Carcinoembryonic AntigenIBA 12/2018
1	fibrin fragment D (D-dimer)IBA 12/2018
1	RNA (Ribonucleic Acid)IBA 12/2018
1	ThymosinIBA 01/2018
1	thiazolyl blueIBA 10/2017
1	Hemoglobins (Hemoglobin)IBA 06/2017
1	salvianolic acid BIBA 09/2016
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2016
1	Biological ProductsIBA 03/2016
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 03/2016
1	1- (2- (3- (4- methoxyphenyl)propoxy)- 4- methoxyphenylethyl)- 1H- imidazoleIBA 03/2016
1	CalciumIBA 03/2016
1	CrizotinibIBA 11/2015
1	Cadherins (E-Cadherin)IBA 09/2015
1	fascinIBA 09/2015
1	Protein Isoforms (Isoforms)IBA 06/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	IntegrinsIBA 02/2014
1	Keratins (Keratin)IBA 02/2014

Therapy/Procedure

8	Therapeutics 07/2019 - 06/2011
6	Radiotherapy 01/2021 - 12/2009
5	Drug Therapy (Chemotherapy) 01/2021 - 04/2004
5	Chemoradiotherapy 01/2021 - 09/2017
2	Immunotherapy 01/2021 - 04/2016
1	Nerve Block (Nerve Blocks) 04/2022
1	Oral Surgery (Maxillofacial Surgery) 04/2022
1	Anesthesia 04/2022
1	Stents 10/2020
1	TP protocol 09/2017